Pulmonary aspergillosis in immunocompromised children.
Seibel
N L
NL
Department of Hematology/Oncology, Children's National Medical Center, Washington, D.C., USA.
Walsh
T J
TJ
D000935:Antifungal Agents / Q000627:therapeutic use; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D006801:Humans; D016867:Immunocompromised Host; D011379:Prognosis
D000935:Antifungal Agents